Inflammatory monocytes recruited to the liver within 24 hours after virus-induced inflammation resemble kupffer cells but are functionally distinct

Journal of Virology

Volumn 89, Issue 9, 2015, Pages 4809-4817

  Movita, Dowty ^a   van de Garde, Martijn D B ^a   Biesta, Paula ^a   Kreefft, Kim ^a   Haagmans, Bart ^a   Zuniga, Elina ^b   Herschke, Florence ^c   De Jonghe, Sandra ^c   Janssen, Harry L A ^a,d   Gama, Lucio ^e   Boonstra, Andre ^a   Vanwolleghem, Thomas ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c JANSSEN RESEARCH FOUNDATION   (Belgium)

^d TORONTO WESTERN HOSPITAL   (Canada)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; INTERLEUKIN 10; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; RNA 18S; TUMOR NECROSIS FACTOR; CYTOKINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL FUNCTION; CELL INFILTRATION; CLONE; CONTROLLED STUDY; GENE EXPRESSION; GENE EXPRESSION PROFILING; IMMUNOHISTOCHEMISTRY; INNATE IMMUNITY; KUPFFER CELL; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MONOCYTE; MOUSE; NONHUMAN; PHAGOCYTOSIS; PHENOTYPE; PRIORITY JOURNAL; TARGET CELL; VIRUS CELL INTERACTION; VIRUS HEPATITIS; ANIMAL; ANIMAL HEPATITIS; C57BL MOUSE; IMMUNOLOGY; LIVER; PATHOLOGY; SECRETION (PROCESS);

ANIMALIA; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MUS;

ANIMALS; CYTOKINES; GENE EXPRESSION PROFILING; HEPATITIS, VIRAL, ANIMAL; KUPFFER CELLS; LIVER; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MICE, INBRED C57BL; MONOCYTES;

EID: 84928563808     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.03733-14     Document Type: Article

References (47)

1. Ganem D, Prince AM. 2004. Hepatitis B virus infection-natural history and clinical consequences. N Engl J Med 350:1118-1129. http://dx.doi.org/10.1056/NEJMra031087.
2. Lauer GM, Walker BD. 2001. Hepatitis C virus infection. N Engl J Med 345:41-52. http://dx.doi.org/10.1056/NEJM200107053450107.
3. Thimme R, Oldach D, Chang KM, Steiger C, Ray SC, Chisari FV. 2001. Determinants of viral clearance and persistence during acute hepatitis C virus infection. J Exp Med 194:1395-1406. http://dx.doi.org/10.1084/jem.194.10.1395.
4. Day CL, Lauer GM, Robbins GK, McGovern B, Wurcel AG, Gandhi RT, Chung RT, Walker BD. 2002. Broad specificity of virus-specific CD4+ T-helper-cell responses in resolved hepatitis C virus infection. J Virol 76: 12584-12595. http://dx.doi.org/10.1128/JVI.76.24.12584-12595.2002.
5. Lauer GM, Ouchi K, Chung RT, Nguyen TN, Day CL, Purkis DR, Reiser M, Kim AY, Lucas M, Klenerman P, Walker BD. 2002. Comprehensive analysis of CD8+ T-cell responses against hepatitis C virus reveals multiple unpredicted specificities. J Virol 76:6104-6113. http://dx.doi.org/10.1128/JVI.76.12.6104-6113.2002.
6. Rehermann B, Nascimbeni M. 2005. Immunology of hepatitis B virus and hepatitis C virus infection. Nat Rev Immunol 5:215-229. http://dx.doi.org/10.1038/nri1573.
7. Claassen MA, Janssen HL, Boonstra A. 2013. Role of T cell immunity in hepatitis C virus infections. Curr Opin Virol 3:461-467. http://dx.doi.org/10.1016/j.coviro.2013.05.006.
8. Chayama K, Hayes CN, Hiraga N, Abe H, Tsuge M, Imamura M. 2011. Animal model for study of human hepatitis viruses. J Gastroenterol Hepatol 26:13-18. http://dx.doi.org/10.1111/j.1440-1746.2010.06470.x.
9. Boonstra A, van der Laan LJ, Vanwolleghem T, Janssen HL. 2009. Experimental models for hepatitis C viral infection. Hepatology 50:1646-1655. http://dx.doi.org/10.1002/hep.23138.
10. Zhou X, Ramachandran S, Mann M, Popkin DL. 2012. Role of lymphocytic choriomeningitis virus (LCMV) in understanding viral immunology: past, present and future. Viruses 4:2650-2669. http://dx.doi.org/10.3390/v4112650.
11. Zuniga EI, Liou LY, Mack L, Mendoza M, Oldstone MB. 2008. Persistent virus infection inhibits type I interferon production by plasmacytoid dendritic cells to facilitate opportunistic infections. Cell Host Microbe 4:374-386. http://dx.doi.org/10.1016/j.chom.2008.08.016.
12. Lee LN, Burke S, Montoya M, Borrow P. 2009. Multiple mechanisms contribute to impairment of type 1 interferon production during chronic lymphocytic choriomeningitis virus infection of mice. J Immunol 182: 7178-7189. http://dx.doi.org/10.4049/jimmunol.0802526.
13. Shi C, Pamer EG. 2011. Monocyte recruitment during infection and inflammation. Nat Rev Immunol 11:762-774. http://dx.doi.org/10.1038/nri3070.
14. Bosschaerts T, Guilliams M, Stijlemans B, Morias Y, Engel D, Tacke F, Herin M, De Baetselier P, Beschin A. 2010. Tip-DC development during parasitic infection is regulated by IL-10 and requires CCL2/CCR2, IFN-γ, and MyD88 signaling. PLoS Pathog 6:e1001045. http://dx.doi.org/10.1371/journal.ppat.1001045.
15. Serbina NV, Salazar-Mather TP, Biron CA, Kuziel WA, Pamer EG. 2003. TNF/iNOS-producing dendritic cells mediate innate immune defense against bacterial infection. Immunity 19:59-70. http://dx.doi.org/10.1016/S1074-7613(03)00171-7.
16. Rivollier A, He J, Kole A, Valatas V, Kelsall BL. 2012. Inflammation switches the differentiation program of Ly6Chi monocytes from antiinflammatory macrophages to inflammatory dendritic cells in the colon. J Exp Med 209:139-155. http://dx.doi.org/10.1084/jem.20101387.
17. Ersland K, Wuthrich M, Klein BS. 2010. Dynamic interplay among monocyte-derived, dermal, and resident lymph node dendritic cells during the generation of vaccine immunity to fungi. Cell Host Microbe 7:474-487. http://dx.doi.org/10.1016/j.chom.2010.05.010.
18. Cheong C, Matos I, Choi JH, Dandamudi DB, Shrestha E, Longhi MP, Jeffrey KL, Anthony RM, Kluger C, Nchinda G, Koh H, Rodriguez A, Idoyaga J, Pack M, Velinzon K, Park CG, Steinman RM. 2010. Microbial stimulation fully differentiates monocytes to DC-SIGN/CD209+ den-dritic cells for immune T cell areas. Cell 143:416-429. http://dx.doi.org/10.1016/j.cell.2010.09.039.
19. Zigmond E, Varol C, Farache J, Elmaliah E, Satpathy AT, Friedlander G, Mack M, Shpigel N, Boneca IG, Murphy KM, Shakhar G, Halpern Z, Jung S. 2012. Ly6Chi monocytes in the inflamed colon give rise to proinflammatory effector cells and migratory antigen-presenting cells. Immunity 37:1076-1090. http://dx.doi.org/10.1016/j.immuni.2012.08.026.
20. Farache J, Koren I, Milo I, Gurevich I, Kim KW, Zigmond E, Furtado GC, Lira SA, Shakhar G. 2013. Luminal bacteria recruit CD103+ dendritic cells into the intestinal epithelium to sample bacterial antigens for presentation. Immunity 38:581-595. http://dx.doi.org/10.1016/j.immuni.2013.01.009.
21. Kurmaeva E, Bhattacharya D, Goodman W, Omenetti S, Merendino A, Berney S, Pizarro T, Ostanin DV. 2014. Immunosuppressive monocytes: possible homeostatic mechanism to restrain chronic intestinal inflammation. J Leukoc Biol 96:377-389. http://dx.doi.org/10.1189/jlb.3HI0613-340RR.
22. Kurihara T, Warr G, Loy J, Bravo R. 1997. Defects in macrophage recruitment and host defense in mice lacking the CCR2 chemokine receptor. J Exp Med 186:1757-1762. http://dx.doi.org/10.1084/jem.186.10.1757.
23. Skold M, Behar SM. 2008. Tuberculosis triggers a tissue-dependent program of differentiation and acquisition of effector functions by circulating monocytes. J Immunol 181:6349-6360. http://dx.doi.org/10.4049/jimmunol.181.9.6349.
24. Dunay IR, Damatta RA, Fux B, Presti R, Greco S, Colonna M, Sibley LD. 2008. Gr1(+) inflammatory monocytes are required for mucosal resistance to the pathogen Toxoplasma gondii. Immunity 29:306-317. http://dx.doi.org/10.1016/j.immuni.2008.05.019.
25. Dawson TC, Beck MA, Kuziel WA, Henderson F, Maeda N. 2000. Contrasting effects of CCR5 and CCR2 deficiency in the pulmonary inflammatory response to influenza A virus. Am J Pathol 156:1951-1959. http://dx.doi.org/10.1016/S0002-9440(10)65068-7.
26. Aldridge JR, Jr, Moseley CE, Boltz DA, Negovetich NJ, Reynolds C, Franks J, Brown SA, Doherty PC, Webster RG, Thomas PG. 2009. TNF/iNOS-producing dendritic cells are the necessary evil of lethal influenza virus infection. Proc Natl Acad Sci USA 106:5306-5311. http://dx.doi.org/10.1073/pnas.0900655106.
27. Holt MP, Cheng L, Ju C. 2008. Identification and characterization of infiltrating macrophages in acetaminophen-induced liver injury. J Leukoc Biol 84:1410-1421. http://dx.doi.org/10.1189/jlb.0308173.
28. Karlmark KR, Weiskirchen R, Zimmermann HW, Gassler N, Ginhoux F, Weber C, Merad M, Luedde T, Trautwein C, Tacke F. 2009. Hepatic recruitment of the inflammatory Gr1+ monocyte subset upon liver injury promotes hepatic fibrosis. Hepatology 50:261-274. http://dx.doi.org/10.1002/hep.22950.
29. Nakamoto N, Ebinuma H, Kanai T, Chu PS, Ono Y, Mikami Y, Ojiro K, Lipp M, Love PE, Saito H, Hibi T. 2012. CCR9+ macrophages are required for acute liver inflammation in mouse models of hepatitis. Gastroenterology 142:366-376. http://dx.doi.org/10.1053/j.gastro.2011.10.039.
30. Helk E, Bernin H, Ernst T, Ittrich H, Jacobs T, Heeren J, Tacke F, Tannich E, Lotter H. 2013. TNFα-mediated liver destruction by Kupffer cells and Ly6Chi monocytes during Entamoeba histolytica infection. PLoS Pathog 9:e1003096. http://dx.doi.org/10.1371/journal.ppat.1003096.
31. Movita D, Kreefft K, Biesta P, van Oudenaren A, Leenen PJ, Janssen HL, Boonstra A. 2012. Kupffer cells express a unique combination of phenotypic and functional characteristics compared with splenic and peritoneal macrophages. J Leukoc Biol 92:723-733. http://dx.doi.org/10.1189/jlb.1111566.
32. Kinoshita M, Uchida T, Sato A, Nakashima M, Nakashima H, Shono S, Habu Y, Miyazaki H, Hiroi S, Seki S. 2010. Characterization of two F4/80-positive Kupffer cell subsets by their function and phenotype in mice. J Hepatol 53:903-910. http://dx.doi.org/10.1016/j.jhep.2010.04.037.
33. Salvato M, Borrow P, Shimomaye E, Oldstone MB. 1991. Molecular basis of viral persistence: a single amino acid change in the glycoprotein of lymphocytic choriomeningitis virus is associated with suppression of the antiviral cytotoxic T-lymphocyte response and establishment of persistence. J Virol 65:1863-1869.
34. Ahmed R, Salmi A, Butler LD, Chiller JM, Oldstone MB. 1984. Selection of genetic variants of lymphocytic choriomeningitis virus in spleens of persistently infected mice. Role in suppression of cytotoxic T lymphocyte response and viral persistence. J Exp Med 160:521-540.
35. Russell JN, Clements JE, Gama L. 2013. Quantitation of gene expression in formaldehyde-fixed and fluorescence-activated sorted cells. PLoS One 8:e73849. http://dx.doi.org/10.1371/journal.pone.0073849.
36. Basta S, Stoessel R, Basler M, van den Broek M, Groettrup M. 2005. Cross-presentation of the long-lived lymphocytic choriomeningitis virus nucleoprotein does not require neosynthesis and is enhanced via heat shock proteins. J Immunol 175:796-805. http://dx.doi.org/10.4049/jimmunol.175.2.796.
37. Lang PA, Recher M, Honke N, Scheu S, Borkens S, Gailus N, Krings C, Meryk A, Kulawik A, Cervantes-Barragan L, Van Rooijen N, Kalinke U, Ludewig B, Hengartner H, Harris N, Haussinger D, Ohashi PS, Zinkernagel RM, Lang KS. 2010. Tissue macrophages suppress viral replication and prevent severe immunopathology in an interferon-I-dependent manner in mice. Hepatology 52:25-32. http://dx.doi.org/10.1016/j.jhep.2009.10.003.
38. Lohler J, Gossmann J, Kratzberg T, Lehmann-Grube F. 1994. Murine hepatitis caused by lymphocytic choriomeningitis virus. I. The hepatic lesions. Lab Invest 70:263-278.
39. Matloubian M, Kolhekar SR, Somasundaram T, Ahmed R. 1993. Molecular determinants of macrophage tropism and viral persistence: importance of single amino acid changes in the polymerase and glycoprotein of lymphocytic choriomeningitis virus. J Virol 67:7340-7349.
40. Rayamajhi M, Humann J, Penheiter K, Andreasen K, Lenz LL. 2010. Induction of IFN-α/β enables Listeria monocytogenes to suppress macrophage activation by IFN-γ. J Exp Med 207:327-337. http://dx.doi.org/10.1084/jem.20091746.
41. Liu BS, Janssen HL, Boonstra A. 2011. IL-29 and IFNα differ in their ability to modulate IL-12 production by TLR-activated human macrophages and exhibit differential regulation of the IFNγ receptor expression. Blood 117:2385-2395. http://dx.doi.org/10.1182/blood-2010-07-298976.
42. Revill K, Wang T, Lachenmayer A, Kojima K, Harrington A, Li JY, Hoshida Y, Llovet JM, Powers S. 2013. Genome-wide methylation analysis and epigenetic unmasking identify tumor suppressor genes in hepatocellular carcinoma. Gastroenterology 145:1424-1435. http://dx.doi.org/10.1053/j.gastro.2013.08.055.
43. Ezekowitz RA, Austyn J, Stahl PD, Gordon S. 1981. Surface properties of bacillus Calmette-Guerin-activated mouse macrophages: reduced expression of mannose-specific endocytosis, Fc receptors, and antigen F4/80 accompanies induction of Ia. J Exp Med 154:60-76.
44. Ezekowitz RA, Gordon S. 1982. Downregulation of mannosyl receptormediated endocytosis and antigen F4/80 in bacillus Calmette-Guerinactivated mouse macrophages: role of T lymphocytes and lymphokines. J Exp Med 155:1623-1637.
45. Liaskou E, Zimmermann HW, Li KK, Oo YH, Suresh S, Stamataki Z, Qureshi O, Lalor PF, Shaw J, Syn WK, Curbishley SM, Adams DH. 2013. Monocyte subsets in human liver disease show distinct phenotypic and functional characteristics. Hepatology 57:385-398. http://dx.doi.org/10.1002/hep.26016.
46. Huang LR, Wohlleber D, Reisinger F, Jenne CN, Cheng RL, Abdullah Z, Schildberg FA, Odenthal M, Dienes HP, van Rooijen N, Schmitt E, Garbi N, Croft M, Kurts C, Kubes P, Protzer U, Heikenwalder M, Knolle PA. 2013. Intrahepatic myeloid-cell aggregates enable local proliferation of CD8+ T cells and successful immunotherapy against chronic viral liver infection. Nat Immunol 14:574-583. http://dx.doi.org/10.1038/ni.2573.
47. Norris BA, Uebelhoer LS, Nakaya HI, Price AA, Grakoui A, Pulendran B. 2013. Chronic but not acute virus infection induces sustained expansion of myeloid suppressor cell numbers that inhibit virus-specific T cell immunity. Immunity 38:309-321. http://dx.doi.org/10.1016/j.immuni.2012.10.022.